Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2007-02-27
2010-11-09
Bernhardt, Emily (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S373000, C544S389000, C544S391000, C544S392000, C544S394000, C544S395000, C544S174000, C544S230000, C544S360000, C544S370000, C544S371000, C544S390000, C540S450000, C540S485000, C540S491000, C540S575000
Reexamination Certificate
active
07829713
ABSTRACT:
The invention includes a compound of formula I:wherein R1, X, Z, n, and m have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of PDE4 function and are useful for improving cognitive function in animals.
REFERENCES:
patent: 2996507 (1961-08-01), Sommers
patent: 3306903 (1967-02-01), Padam et al.
patent: 3857945 (1974-12-01), Najer et al.
patent: 4093726 (1978-06-01), Winn et al.
patent: 5086055 (1992-02-01), Walsh et al.
patent: 6555572 (2003-04-01), Lauener et al.
patent: 6953801 (2005-10-01), Hutchison et al.
patent: 7429666 (2008-09-01), Lachance et al.
patent: 7439243 (2008-10-01), Johnson et al.
patent: 7589199 (2009-09-01), Pennell et al.
patent: 7625889 (2009-12-01), Eastwood et al.
patent: 2003/0220352 (2003-11-01), Lauener et al.
patent: 23 45 422 (1975-03-01), None
patent: 0 185 909 (1986-07-01), None
patent: 0 202 760 (1986-11-01), None
patent: 0 277 725 (1988-08-01), None
patent: 0 511 879 (1992-11-01), None
patent: 0 527 081 (1993-02-01), None
patent: 2 551 753 (1985-03-01), None
patent: 1 575 904 (1980-10-01), None
patent: 2 101 580 (1983-01-01), None
patent: 200168600 (2001-09-01), None
patent: WO 2004/024728 (2004-03-01), None
patent: WO 2004/103998 (2004-12-01), None
patent: WO 2006/111549 (2006-10-01), None
Ferrand, G. et al., Synthesis of new 1,2,3-traizin-4-ones as Potential anti-Depressants. Synthese et Activite Anti-Depressive Potentielle De Nouvelles Traizine-1,2,3 Ones-4 European Journal of Medicinal Chemistry, Editions Scientifique Elsevier, Paris, FR, vol. 22, No. 4 (1987) pp. 337-345 XP002396679 ISSN: 0223-5234.
Bosc, J. J. et al.: “Synthesis and Antidepressant Activity of 5-(1-aryl-4-piperazino) Methyl-2-Amino-2-Oxazolines” European Journal of Medicinal Chemistry, 27(5), pp. 437-442 Coden: EJMCA5; ISSN: 0223-5234 (1992) XP002444447.
Heinrich, T et al., :Indolebutylamines as Selective 5-HT1A Agonists Journal of medicinal Chemistry, 47(19), pp. 4677-4683 Coden: JMCMAR; ISSN: 0022-2623 (2004) XP002444448.
Kaplan Alan P.
Keenan Terrence P.
Bernhardt Emily
Helicon Therapeutics, Inc.
Pelto Don J.
Sheppard Mullin Richter & Hampton LLP
LandOfFree
Therapeutic piperazines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic piperazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic piperazines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4242286